Rockwell Medical, Inc. SEC filings RMTI
Rockwell Medical, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Oct 29, 2009. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (material agreement, unregistered share sale, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Nov 3, 2026 | Nov 2, 2026 |
| 4 | Insider transaction | Oct 5, 2026 | Oct 1, 2026 |
| 144 | Notice of proposed sale | Oct 1, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 13, 2026 | Aug 13, 2026 |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2026 | Aug 13, 2026 |
| 8-K |
Current report
Other events
|
Jul 20, 2026 | Jul 20, 2026 |
| 4 | Insider transaction | Jul 6, 2026 | Jul 1, 2026 |
| 4 | Insider transaction | Jul 6, 2026 | Jul 1, 2026 |
| 4 | Insider transaction | Jul 6, 2026 | Jul 1, 2026 |
| 4 | Insider transaction | Jul 6, 2026 | Jul 1, 2026 |
| 4 | Insider transaction | Jul 6, 2026 | Jul 1, 2026 |
| 4 | Insider transaction | Jul 6, 2026 | Jul 1, 2026 |
| 4 | Insider transaction | Jul 6, 2026 | Jul 1, 2026 |
| 4 | Insider transaction | Jul 6, 2026 | Jul 1, 2026 |
| 4 | Insider transaction | Jul 6, 2026 | Jul 1, 2026 |
| 4 | Insider transaction | Jul 6, 2026 | Jul 1, 2026 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Jun 29, 2026 | Jun 24, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 15, 2026 | Jun 12, 2026 |
| DEFA14A | Additional proxy material | May 11, 2026 | — |
| 8-K |
Current report
Listing notice
|
May 8, 2026 | May 8, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
May 7, 2026 | May 7, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| ARS | Annual report to shareholders | Apr 30, 2026 | Dec 31, 2025 |
| DEF 14A | Proxy statement | Apr 30, 2026 | Apr 30, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 20, 2026 | Apr 20, 2026 |
| 4/A | Ownership document | Apr 17, 2026 | May 20, 2025 |
| 4/A | Ownership document | Apr 17, 2026 | May 20, 2025 |
| 4/A | Ownership document | Apr 17, 2026 | May 20, 2025 |
| 4/A | Ownership document | Apr 17, 2026 | May 20, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 26, 2026 | Mar 26, 2026 |
| 10-K | Annual report | Mar 26, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 26, 2026 | Mar 26, 2026 |
| 4 | Insider transaction | Mar 16, 2026 | Mar 14, 2026 |
| 4 | Insider transaction | Mar 16, 2026 | Mar 14, 2026 |
| 4 | Insider transaction | Mar 16, 2026 | Mar 14, 2026 |
| 4 | Insider transaction | Mar 16, 2026 | Mar 14, 2026 |
| 4 | Insider transaction | Mar 16, 2026 | Mar 14, 2026 |
| 8-K |
Current report
Results of operations
|
Jan 20, 2026 | Jan 20, 2026 |
| 4 | Insider transaction | Jan 5, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 5, 2026 | Jan 2, 2026 |
| 144 | Notice of proposed sale | Jan 5, 2026 | — |
| 8-K |
Current report
Other events
|
Jan 5, 2026 | Dec 31, 2025 |
| 144 | Notice of proposed sale | Jan 2, 2026 | — |
| 4 | Insider transaction | Nov 20, 2025 | Nov 17, 2025 |
| 3 | Initial insider ownership | Nov 20, 2025 | Nov 17, 2025 |
| 4 | Insider transaction | Nov 18, 2025 | Nov 18, 2025 |
| 144 | Notice of proposed sale | Nov 18, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Nov 18, 2025 | Nov 17, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 12, 2025 | Nov 12, 2025 |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2025 | Nov 12, 2025 |
| 4 | Insider transaction | Oct 8, 2025 | Oct 1, 2025 |
| 3 | Initial insider ownership | Oct 8, 2025 | Sep 23, 2025 |
| 144 | Notice of proposed sale | Oct 1, 2025 | — |
| 4 | Insider transaction | Oct 1, 2025 | Oct 1, 2025 |
| 4 | Insider transaction | Oct 1, 2025 | Oct 1, 2025 |
| 4 | Insider transaction | Oct 1, 2025 | Oct 1, 2025 |
| 144 | Notice of proposed sale | Oct 1, 2025 | — |
| 144 | Notice of proposed sale | Oct 1, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Sep 29, 2025 | Sep 23, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 14, 2025 | — |
| S-8 | Employee stock plan registration | Aug 14, 2025 | — |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2025 | Aug 14, 2025 |
| 4/A | Form 4/a | Jul 3, 2025 | Jul 1, 2025 |
| 4/A | Form 4/a | Jul 3, 2025 | Jul 1, 2025 |
| 4/A | Form 4/a | Jul 3, 2025 | Jul 1, 2025 |
| 4 | Insider transaction | Jul 2, 2025 | Jul 1, 2025 |
| 4 | Insider transaction | Jul 2, 2025 | Jul 1, 2025 |
| 4 | Insider transaction | Jul 2, 2025 | Jul 1, 2025 |
| 144 | Notice of proposed sale | Jul 1, 2025 | — |
| 144 | Notice of proposed sale | Jul 1, 2025 | — |
| 144 | Notice of proposed sale | Jul 1, 2025 | — |
| 4 | Insider transaction | May 21, 2025 | May 20, 2025 |
| 4 | Insider transaction | May 21, 2025 | May 20, 2025 |
| 4 | Insider transaction | May 21, 2025 | May 20, 2025 |
| 4 | Insider transaction | May 21, 2025 | May 20, 2025 |
| 4 | Insider transaction | May 21, 2025 | May 20, 2025 |
| 4 | Insider transaction | May 21, 2025 | May 20, 2025 |
| 4 | Insider transaction | May 21, 2025 | May 20, 2025 |
| 4 | Insider transaction | May 21, 2025 | May 20, 2025 |
| 4 | Insider transaction | May 21, 2025 | May 20, 2025 |
| 4 | Insider transaction | May 21, 2025 | May 20, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 20, 2025 | May 20, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
May 12, 2025 | May 12, 2025 |
| 10-Q | Quarterly report | May 12, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 12, 2025 | May 12, 2025 |
| 4 | Insider transaction | Apr 15, 2025 | Apr 10, 2025 |
| ARS | Annual report to shareholders | Apr 14, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Apr 14, 2025 | May 20, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Apr 1, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Apr 1, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Apr 1, 2025 |
| 144 | Notice of proposed sale | Apr 1, 2025 | — |
| 144 | Notice of proposed sale | Apr 1, 2025 | — |
| 144 | Notice of proposed sale | Apr 1, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 20, 2025 | Mar 20, 2025 |
| 10-K | Annual report | Mar 20, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 20, 2025 | Mar 20, 2025 |
| 4 | Insider transaction | Mar 18, 2025 | Mar 14, 2025 |
| 4 | Insider transaction | Mar 18, 2025 | Mar 14, 2025 |
| 4 | Insider transaction | Mar 18, 2025 | Mar 14, 2025 |
| 4 | Insider transaction | Mar 18, 2025 | Mar 14, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| 4 | Insider transaction | Jan 6, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 6, 2025 | Jan 2, 2025 |
| 144 | Notice of proposed sale | Jan 2, 2025 | — |
| 144 | Notice of proposed sale | Jan 2, 2025 | — |
| 3 | Initial insider ownership | Dec 19, 2024 | Dec 12, 2024 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Dec 17, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Dec 12, 2024 | Dec 10, 2024 |
| 4 | Insider transaction | Nov 19, 2024 | Nov 15, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| 8-K |
Current report
Other events
|
Nov 13, 2024 | Nov 13, 2024 |
| 424B5 | Prospectus supplement | Nov 13, 2024 | — |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 12, 2024 | Nov 12, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2024 | Nov 12, 2024 |
| EFFECT | Filing | Oct 21, 2024 | — |
| CORRESP | Letter to the SEC | Oct 17, 2024 | — |
| CORRESP | Letter to the SEC | Oct 17, 2024 | — |
| UPLOAD | Letter from the SEC | Oct 15, 2024 | — |
| S-8 | Employee stock plan registration | Oct 8, 2024 | — |
| S-3 | Shelf registration | Oct 8, 2024 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 3, 2024 | — |
| 4 | Insider transaction | Oct 2, 2024 | Oct 1, 2024 |
| 4 | Insider transaction | Oct 2, 2024 | Oct 1, 2024 |
| 144 | Notice of proposed sale | Oct 1, 2024 | — |
| 144 | Notice of proposed sale | Oct 1, 2024 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 20, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 8, 2024 | Aug 8, 2024 |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K | Current report | Aug 8, 2024 | Aug 8, 2024 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 2, 2024 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 16, 2024 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jul 15, 2024 | Jul 12, 2024 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 1, 2024 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jun 25, 2024 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jun 13, 2024 | — |
| 3 | Initial insider ownership | May 30, 2024 | May 21, 2024 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 30, 2024 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 30, 2024 | — |
| 4 | Insider transaction | May 23, 2024 | May 21, 2024 |
| 4 | Insider transaction | May 23, 2024 | May 21, 2024 |
| 4 | Insider transaction | May 23, 2024 | May 21, 2024 |
| 4 | Insider transaction | May 23, 2024 | May 21, 2024 |
| 4 | Insider transaction | May 23, 2024 | May 21, 2024 |
| 4 | Insider transaction | May 23, 2024 | May 21, 2024 |
| 8-K |
Current report
Shareholder vote results
|
May 23, 2024 | May 21, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
May 14, 2024 | May 14, 2024 |
| 10-Q | Quarterly report | May 14, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 14, 2024 | May 14, 2024 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 3, 2024 | — |
| ARS | Annual report to shareholders | Apr 15, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Apr 15, 2024 | May 21, 2024 |
| 10-K | Annual report | Mar 21, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 21, 2024 | Mar 21, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 21, 2024 | Mar 21, 2024 |
| 4 | Insider transaction | Mar 19, 2024 | Mar 17, 2024 |
| 4 | Insider transaction | Mar 19, 2024 | Mar 17, 2024 |
| 4 | Insider transaction | Mar 15, 2024 | Mar 14, 2024 |
| 4 | Insider transaction | Mar 15, 2024 | Mar 14, 2024 |
| 4 | Insider transaction | Mar 15, 2024 | Mar 14, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| 4/A | Ownership document | Feb 6, 2024 | Oct 16, 2023 |
| 3/A | Ownership document | Feb 6, 2024 | Oct 16, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 9, 2024 | Jan 8, 2024 |
| 8-K |
Current report
Material agreement, Results of operations, New debt, Unregistered share sale, Other events
|
Jan 8, 2024 | Jan 2, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 14, 2023 | Nov 14, 2023 |
| 10-Q | Quarterly report | Nov 14, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2023 | Nov 14, 2023 |
| 4 | Insider transaction | Oct 18, 2023 | Oct 16, 2023 |
| 4 | Insider transaction | Oct 18, 2023 | Oct 16, 2023 |
| 3 | Initial insider ownership | Oct 18, 2023 | Oct 16, 2023 |
| 3 | Initial insider ownership | Oct 18, 2023 | Oct 16, 2023 |
| 8-K |
Current report
Officer or director change
|
Oct 17, 2023 | Oct 16, 2023 |
| 8-K |
Current report
Material agreement
|
Sep 21, 2023 | Sep 18, 2023 |
| 8-K |
Current report
Officer or director change
|
Sep 15, 2023 | Sep 13, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 12, 2023 | Sep 12, 2023 |
| SC 13D/A | Amended ownership over 5% (active) | Sep 6, 2023 | — |
| EFFECT | Filing | Aug 22, 2023 | — |
| CORRESP | Letter to the SEC | Aug 21, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 18, 2023 | — |
| S-8 | Employee stock plan registration | Aug 15, 2023 | — |
| S-3 | Shelf registration | Aug 15, 2023 | — |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2023 | Aug 14, 2023 |
| 8-K |
Current report
Material agreement, Results of operations, Unregistered share sale, Change to shareholder rights, Regulation FD disclosure, Other events
|
Jul 11, 2023 | Jul 10, 2023 |
| 4 | Insider transaction | May 25, 2023 | May 23, 2023 |
| 4 | Insider transaction | May 25, 2023 | May 23, 2023 |
| 4 | Insider transaction | May 25, 2023 | May 23, 2023 |
| 4 | Insider transaction | May 25, 2023 | May 23, 2023 |
| 4 | Insider transaction | May 25, 2023 | May 23, 2023 |
| 8-K |
Current report
Shareholder vote results
|
May 23, 2023 | May 23, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
May 15, 2023 | May 15, 2023 |
| 10-Q | Quarterly report | May 15, 2023 | Mar 31, 2023 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- RMTI (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Wixom, MI
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1041024
- Former names
- ROCKWELL MEDICAL TECHNOLOGIES INC (until Jun 14, 2012)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.